Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer

Journal of Clinical Oncology

Volumn 25, Issue 33, 2007, Pages 5158-5164

  Lu, Karen H ^a   Schorge, John O ^a   Rodabaugh, Kerry J ^a   Daniels, Molly S ^a   Sun, Charlotte C ^a   Soliman, Pamela T ^a   White, Kristin G ^a   Luthra, Rajyalakshmi ^a   Gershenson, David M ^a   Broaddus, Russell R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METHYLATION; MICROSATELLITE INSTABILITY; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; WOMEN'S HEALTH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGE FACTORS; BODY MASS INDEX; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GERM-LINE MUTATION; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 36549086274     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.10.8597     Document Type: Article

References (27)

1. Aarnio M, Sankila R, Pukkala E, et al: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214-218, 1999
2. Dunlop MG, Farrington SM, Carothers AD, et al: Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6:105-110, 1997
3. Vasen HF, Watson P, Mecklin JP, et al: The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. Anticancer Res 14:1675-1678, 1994
4. Fishel R, Lescoe MK, Rao MR, et al: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038, 1993
5. Leach FS, Nicolaides NC, Papadopoulos N, et al: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225, 1993
6. Peltomäki P, Vasen HF: Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study - The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 113:1146-1158, 1997
7. Vasen HF, Watson P, Mecklin JP, et al: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453-1456, 1999
8. Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004
9. Lu K, et al: Gynecological malignancy as a "sentinel cancer" for women with HNPCC. Gynecol Oncol 92:421, 2004
10. Soliman PT, Broaddus RR, Schmeler KM, et al: Women with synchronous primary cancers of the endometrium and ovary: Do they have Lynch syndrome? J Clin Oncol 23:9344-9350, 2005
11. Berends MJ, Wu Y, Sijmons RH, et al: Molecular and clinical characteristics of MSH6 variants: An analysis of 25 index carriers of a germline variant. Am J Hum Genet 70:26-37, 2002
12. Wijnen J, de Leeuw W, Vasen H, et al: Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23:142-144, 1999
13. Goodfellow PJ, Buttin BM, Herzog TJ, et al: Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U S A 100:5908-5913, 2003
14. Vasen HF, Stormorken A, Menko FH, et al: MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19:4074-4080, 2001
15. Berends MJ, Wu Y, Sijmons RH, et al: Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J Clin Oncol 21:4364-4370, 2003
16. Hampel H, Frankel W, Panescu J, et al: Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66:7810-7817, 2006
17. de Jong AE, van Puijenbroek M, Hendriks Y, et al: Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:972-980, 2004
18. Broaddus RR, Lynch HT, Chen LM, et al: Pathologic features of endometrial carcinoma associated with HNPCC: A comparison with sporadic endometrial carcinoma. Cancer 106:87-94, 2006
19. Millar AL, Pal T, Madlensky L, et al: Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. Hum Mol Genet 8:823-829, 1999
20. Evans-Metcalf ER, Brooks SE, Reale FR, et al: Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 91:349-354, 1998
21. Tran BN, Connell PP, Waggoner S, et al: Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol 23:476-480, 2000
22. Gitsch G, Hanzal E, Jensen D, et al: Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 85:504-508, 1995
23. Soliman PT, Oh JC, Schmeler KM, et al: Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105:575-580, 2005
24. Zaino R, Whitney C, Brady MF, et al: Simultaneously detected endometrial and ovarian carcinomas-a prospective clinicopathologic study of 74 cases: A gynecologic oncology group study. Gynecol Oncol 83:355-362, 2001
25. Soliman PT, Slomovitz BM, Broaddus RR, et al: Synchronous primary cancers of the endometrium and ovary: A single institution review of 84 cases. Gynecol Oncol 94:456-462, 2004
26. Shannon C, Kirk J, Barnetson R, et al: Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. Clin Cancer Res 9:1387-1392, 2003
27. Brinton LA, Berman ML, Mortel R, et al: Reproductive, menstrual, and medical risk factors for endometrial cancer: Results from a casecontrol study. Am J Obstet Gynecol 167:1317-1325, 1992